Vandazole
Diverticulitis
Thomas Jefferson UniversitySmall moleculeEarly Phase 1Dormant
C
39/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 24/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Diverticulitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Marcaine Des Moines University | Phase 4 | BBB |
Hextend Corewell Health West | Phase 3 | BB |
Lidocaine Franco Carli | Phase 2 | B |
Nepenthe McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 1/2 | CCC |
Neomycin Thomas Jefferson University | Early Phase 1 | C |
Macrogols Thomas Jefferson University | Early Phase 1 | C |
Caffeine Thomas Steffen | N/A | D |
Same molecule, other indications
Vandazole is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →